PGS Publication: PGP000760

Publication Information (EuropePMC)
Title Genetic liability to psoriasis predicts severe disease outcomes.
PubMed ID 41408349(Europe PMC)
doi 10.1186/s13073-025-01561-2
Publication Date Dec. 17, 2025
Journal Genome Med
Author(s) Saklatvala JR, Lessard S, Teder-Laving M, Thomas LF, Ramessur R, Zierer J, Åsvold BO, Barton A, Baudry D, Bowes J, Brumpton B, Bruno S, Chandran V, Chatelain C, de Rinaldis E, Elder JT, Ellinghaus D, Foerster J, Franke A, Gladman DD, Gulliver W, Hüffmeier U, Huilaja L, Hveem K, Khader S, Kingo K, Klinger K, Kolbinger F, Kõks S, Liao W, Nair RP, Nititham J, Rahman P, Reis A, Sagoo MK, Stuart PE, Tasanen K, Traks T, Tsoi LC, Uebe S, Watts K, BSTOP study group, Barker JN, Mahil SK, Langan SM, FinnGen, Estonian Biobank research team, Brown SJ, Løset M, Paternoster L, Dand N, Smith CH, Simpson MA.
Released in PGS Catalog: Jan. 19, 2026

Associated Polygenic Score(s)

Filter PGS by Participant Ancestry
Individuals included in:
G - Source of Variant Associations (GWAS)
D - Score Development/Training
E - PGS Evaluation
List of ancestries includes:
Display options:
Ancestry legend
Multi-ancestry (including European)
Multi-ancestry (excluding European)
African
East Asian
South Asian
Additional Asian Ancestries
European
Greater Middle Eastern
Hispanic or Latin American
Additional Diverse Ancestries
Not Reported

PGS Developed By This Publication

Polygenic Score ID & Name PGS Publication ID (PGP) Reported Trait Mapped Trait(s) (Ontology) Number of Variants Ancestry distribution
GWAS
Dev
Eval
Scoring File (FTP Link)
PGS005308
(GWS-noHLA)
PGP000760 |
Saklatvala JR et al. Genome Med (2025)
Psoriasis psoriasis 64
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS005308/ScoringFiles/PGS005308.txt.gz
PGS005310
(Full-noHLA)
PGP000760 |
Saklatvala JR et al. Genome Med (2025)
Psoriasis psoriasis 513,460
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS005310/ScoringFiles/PGS005310.txt.gz
PGS005307
(GWS)
PGP000760 |
Saklatvala JR et al. Genome Med (2025)
Psoriasis psoriasis 64
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS005307/ScoringFiles/PGS005307.txt.gz
PGS005311
(Full_subset)
PGP000760 |
Saklatvala JR et al. Genome Med (2025)
Psoriasis psoriasis 487,311
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS005311/ScoringFiles/PGS005311.txt.gz
PGS005312
(Full-noHLA_subset)
PGP000760 |
Saklatvala JR et al. Genome Med (2025)
Psoriasis psoriasis 487,310
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS005312/ScoringFiles/PGS005312.txt.gz
PGS005309
(Full)
PGP000760 |
Saklatvala JR et al. Genome Med (2025)
Psoriasis psoriasis 513,461
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS005309/ScoringFiles/PGS005309.txt.gz

Performance Metrics

Disclaimer: The performance metrics are displayed as reported by the source studies. It is important to note that metrics are not necessarily comparable with each other. For example, metrics depend on the sample characteristics (described by the PGS Catalog Sample Set [PSS] ID), phenotyping, and statistical modelling. Please refer to the source publication for additional guidance on performance.

PGS Performance
Metric ID (PPM)
Evaluated Score PGS Sample Set ID
(PSS)
Performance Source Trait PGS Effect Sizes
(per SD change)
Classification Metrics Other Metrics Covariates Included in the Model PGS Performance:
Other Relevant Information
PPM023015 PGS005307
(GWS)
PSS012098|
European Ancestry|
9,426 individuals
PGP000760 |
Saklatvala JR et al. Genome Med (2025)
Reported Trait: Severe psoriasis OR: 1.19 [1.12, 1.26]
PPM023016 PGS005308
(GWS-noHLA)
PSS012098|
European Ancestry|
9,426 individuals
PGP000760 |
Saklatvala JR et al. Genome Med (2025)
Reported Trait: Severe psoriasis OR: 1.22 [1.15, 1.3]
PPM023017 PGS005309
(Full)
PSS012098|
European Ancestry|
9,426 individuals
PGP000760 |
Saklatvala JR et al. Genome Med (2025)
Reported Trait: Severe psoriasis OR: 1.33 [1.25, 1.41]
PPM023018 PGS005310
(Full-noHLA)
PSS012098|
European Ancestry|
9,426 individuals
PGP000760 |
Saklatvala JR et al. Genome Med (2025)
Reported Trait: Severe psoriasis OR: 1.4 [1.32, 1.49]
PPM023019 PGS005307
(GWS)
PSS012094|
European Ancestry|
14,167 individuals
PGP000760 |
Saklatvala JR et al. Genome Med (2025)
Reported Trait: Severe psoriasis OR: 1.44 [1.36, 1.51]
PPM023020 PGS005308
(GWS-noHLA)
PSS012094|
European Ancestry|
14,167 individuals
PGP000760 |
Saklatvala JR et al. Genome Med (2025)
Reported Trait: Severe psoriasis OR: 1.25 [1.18, 1.31]
PPM023021 PGS005309
(Full)
PSS012094|
European Ancestry|
14,167 individuals
PGP000760 |
Saklatvala JR et al. Genome Med (2025)
Reported Trait: Severe psoriasis OR: 1.49 [1.41, 1.57]
PPM023022 PGS005310
(Full-noHLA)
PSS012094|
European Ancestry|
14,167 individuals
PGP000760 |
Saklatvala JR et al. Genome Med (2025)
Reported Trait: Severe psoriasis OR: 1.38 [1.31, 1.45]
PPM023023 PGS005307
(GWS)
PSS012096|
European Ancestry|
8,603 individuals
PGP000760 |
Saklatvala JR et al. Genome Med (2025)
Reported Trait: Severe psoriasis OR: 1.26 [1.19, 1.33]
PPM023024 PGS005308
(GWS-noHLA)
PSS012096|
European Ancestry|
8,603 individuals
PGP000760 |
Saklatvala JR et al. Genome Med (2025)
Reported Trait: Severe psoriasis OR: 1.23 [1.17, 1.31]
PPM023025 PGS005309
(Full)
PSS012096|
European Ancestry|
8,603 individuals
PGP000760 |
Saklatvala JR et al. Genome Med (2025)
Reported Trait: Severe psoriasis OR: 1.29 [1.22, 1.36]
PPM023026 PGS005310
(Full-noHLA)
PSS012096|
European Ancestry|
8,603 individuals
PGP000760 |
Saklatvala JR et al. Genome Med (2025)
Reported Trait: Severe psoriasis OR: 1.25 [1.19, 1.33]
PPM023027 PGS005307
(GWS)
PSS012095|
European Ancestry|
12,708 individuals
PGP000760 |
Saklatvala JR et al. Genome Med (2025)
Reported Trait: Severe psoriasis OR: 1.22 [1.17, 1.26]
PPM023028 PGS005308
(GWS-noHLA)
PSS012095|
European Ancestry|
12,708 individuals
PGP000760 |
Saklatvala JR et al. Genome Med (2025)
Reported Trait: Severe psoriasis OR: 1.19 [1.15, 1.24]
PPM023029 PGS005309
(Full)
PSS012095|
European Ancestry|
12,708 individuals
PGP000760 |
Saklatvala JR et al. Genome Med (2025)
Reported Trait: Severe psoriasis OR: 1.23 [1.18, 1.27]
PPM023030 PGS005310
(Full-noHLA)
PSS012095|
European Ancestry|
12,708 individuals
PGP000760 |
Saklatvala JR et al. Genome Med (2025)
Reported Trait: Severe psoriasis OR: 1.23 [1.18, 1.28]
PPM023031 PGS005311
(Full_subset)
PSS012093|
European Ancestry|
13,577 individuals
PGP000760 |
Saklatvala JR et al. Genome Med (2025)
Reported Trait: Severe psoriasis (BSTOP) vs. any psoriasis (UKB) Percentage of cases with risk >95th percentile of UKB psoraisis cases: 15.3
PPM023032 PGS005312
(Full-noHLA_subset)
PSS012093|
European Ancestry|
13,577 individuals
PGP000760 |
Saklatvala JR et al. Genome Med (2025)
Reported Trait: Severe psoriasis (BSTOP) vs. any psoriasis (UKB) Percentage of cases with risk >95th percentile of UKB psoraisis cases: 15.3
PPM023033 PGS005311
(Full_subset)
PSS012097|
European Ancestry|
10,887 individuals
PGP000760 |
Saklatvala JR et al. Genome Med (2025)
Reported Trait: Severe psoriasis (Novartis) vs. any psoriasis (UKB) Percentage of cases with risk >95th percentile of UKB psoraisis cases: 11.6
PPM023034 PGS005312
(Full-noHLA_subset)
PSS012097|
European Ancestry|
10,887 individuals
PGP000760 |
Saklatvala JR et al. Genome Med (2025)
Reported Trait: Severe psoriasis (Novartis) vs. any psoriasis (UKB) Percentage of cases with risk >95th percentile of UKB psoraisis cases: 11.5

Evaluated Samples

PGS Sample Set ID
(PSS)
Phenotype Definitions and Methods Participant Follow-up Time Sample Numbers Age of Study Participants Sample Ancestry Additional Ancestry Description Cohort(s) Additional Sample/Cohort Information
PSS012093 4,151 individuals European BSTOP 4,151 in BSTOP is compared against 9426 UKB
PSS012093 9,426 individuals European UKB 4,151 in BSTOP is compared against 9426 UKB
PSS012094
[
  • 1,639 cases
  • , 12,528 controls
]
European
(Estonian)
EB
PSS012095
[
  • 5,365 cases
  • , 7,343 controls
]
European
(Finnish)
FinnGen
PSS012096
[
  • 1,491 cases
  • , 7,112 controls
]
European
(Norwegian)
HUNT
PSS012097 1,461 individuals European Novartis 1,461 in Novartis is compared against 9426 UKB
PSS012097 9,426 individuals European UKB 1,461 in Novartis is compared against 9426 UKB
PSS012098
[
  • 1,243 cases
  • , 8,183 controls
]
European
(British)
UKB